Published date: 25 January 2023
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Research laboratory services - 73111000
Location of contract
England
Value of contract
£80,000 to £90,000
Procurement reference
NCL001-DN652992-56918617
Published date
25 January 2023
Closing date
16 February 2023
Closing time
12pm
Contract start date
21 February 2023
Contract end date
25 June 2023
Contract type
Service contract
Procedure type
Other
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
The Newcastle University Biosciences Institute is one of three research institutes established in 2019 following a restructure within the Faculty of Medical Sciences. Its members map across the biomedical research landscape. A number of major research projects are led from within the Institute including this investigation into genetic influences upon DNA methylation during development, ageing and disease of the human hip. This project funded by Versus Arthritis aims to investigate how a transcription factor (RUNX2) is regulated epigenetically in development and in later life, contributing to a range of traits and diseases including height, hip shape, facial morphology, osteoarthritis, and osteoporosis.
The purpose of this tender process is to engage a supplier to run Illumina MethylationEPIC and Infinium Global Screening Arrays to generate both DNA methylation and genotype data on 360 supplied DNA samples. Samples will be supplied for processing in 1 batch in early 2022 (Feb-March).
About the buyer
Contact name
Emma Barksby
Address
Newcastle University
Procurement Services, Kingsgate
Newcastle
NE1 7RU
England
Telephone
+44 1912086298
Website
Share this notice
Closing: 16 February 2023, 12pm
All content is available under the
